Friday, 3 May 2024
  
Login

Australia's most trusted
source of pharma news

Friday, 3 May 2024
Ascott/Vivacity
Ascott/Vivacity
Who has the Greenest office of all?

This company's move to a new Sydney HQ in 2022 is paying dividends on its commitment to environmental sustainability with the office tower where it has taken up residence recognised as Australia's most energy-efficient commercial building.

Company restructure hits jobs
ICYMI: The stories that topped this week
TODAY Your Week in Five Minutes
Fastest growing skills in pharma
The new must-have capabilities for Aussie companies
TODAY
Company defies PR nightmare
Voted number one by HCPs despite high-profile drug fail
TODAY
JPD
JPD
Drug ready to take PBS throne
Challenger in neck-and-neck battle for top earner spot
2 May
Novartis exec nabs new role
Moves to ASX company after extensive Big Pharma career
2 May
How big can this company get?
Pharma's market cap grows by a third... in just three months
1 May
Aussie company losses CEO
Ex-Big Pharma heavyweight gives notice of resignation
1 May
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (24)

Clinical & Medical, R&D (9)

Regulatory, Pharmacovigilance & QA (10)

Other (27)

Seqirus signs neffy deal
New delivery format could revitalise life-saving market
TODAY
Cancer crusher sends shares flying
Remarkable prostate cancer success raises company fortunes
TODAY
Trials shake-up arrives... after 15yrs
Part of Govt $1.8B 'once-in-a-generation transformation'
2 May
PBS listings swell by 12 in May
Ranging from new additions, a generic, and expansions
2 May New to the PBS
CAR T works even better in real life
Will real world results loosen funding purse strings?
2 May
Down Under deal for RNAi drugs
'One-of-a-kind unified commercial platform' includes Australia
2 May
AbbVie's game-changing PBS nod
Number of injections patients require each year, halved
1 May
Boost to local precision medicine
Illumina and Garvan join forces in $27M investment
1 May
Hyped heart drugs win subsidy
New treatment options for cardiomyopathy added to the PBS
1 May
CSL Vifor addresses EU antitrust
Proposal to rectify past messaging about a rival product
1 May
There's a new World's Best Pharma
But overall, industry's reputation suffers a fall in Australia
30 April
Pharmas snap up $25B in deals
Who went shopping for blockbuster hopefuls Q1?
30 April
BMS braves another shortage
Manufacturing issues anticipated to have a domino effect
30 April
Cancer drugs on the horizon
EU decisions a good omen for drugs under TGA review
30 April
PiF jobs
PiF jobs
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.